Sabra Healthcare REIT

SBRA

Market cap $4.8B

In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+. Capital One Financial. After they acquired Discover, I was not sure what to expect.

TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served.

The Investment Committee detail their top picks for 2026 and explain why these names are may go higher during the year.

My update on Sabra Health Care REIT upgrades it to a strong buy. Although technical indicators point to a hold, several fundamentals drive the needle into the highly bullish range, particularly portfolio growth and macro demand in this niche of senior care. AFFO dividend coverage is adequate, though the payout ratio is slightly elevated at around 81%.

Sabra Health Care REIT presents a compelling value-income opportunity, offering a 6.4% yield and robust fundamentals. SBRA's SHOP segment drives growth, with same-store NOI up 13.3% and significant new investments targeting a 40% SHOP NOI mix. It received an investment-grade rating, has safe leverage, and has no debt maturities until 2027, supporting dividend safety.

The Investment Committee give you their top stocks to watch for the second half.

The price-to-net asset value valuations for publicly listed US equity real estate investment trusts rose in November, after two consecutive months of decline. US equity REITs closed November at a median 18.2% discount to their consensus NAV per share estimates, according to S&P Global Market Intelligence data. Healthcare REITs posted the highest median premium to NAV.

The REIT sector has seen back-to-back tough months as it saw a modest average negative total return in September (-0.73%) and fell deeper into the red in October (-4.03%). Small cap REITs (-5.05%) had the worst performance in October. Micro caps (-2.81%), mid caps (-3.11%) and large caps (-4.45%) were also in negative territory albeit to a smaller degree. Only 21.66% of REIT securities had a positive total return in October.

Sabra Health Care REIT, Inc. ( SBRA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Darrin Smith - Executive Vice President of Investments Michael Costa - Executive VP, CFO & Secretary Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division William John Kilichowski - Wells Fargo Securities, LLC, Research Division Seth Bergey - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good day, everyone.

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.